This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2fm0

From Proteopedia

Revision as of 20:00, 12 November 2007 by OCA (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search

2fm0, resolution 2.Å

Drag the structure with the mouse to rotate

Crystal structure of PDE4D in complex with L-869298

Contents

Overview

Type 4 phosphodiesterase (PDE4) inhibitors are emerging as new treatments, for a number of disorders including asthma and chronic obstructive, pulmonary disease. Here we report the biochemical characterization on the, second generation inhibitor (+)-1 (L-, IC50=0.4 nM) and its enantiomer, (-)-1 (L-, IC50=43 nM) and their cocrystal structures with PDE4D at 2.0 A, resolution. Despite the 107-fold affinity difference, both enantiomers, interact with the same sets of residues in the rigid active site. The, weaker (-)-1 adopts an unfavorable conformation to preserve the pivotal, interactions between the Mg-bound waters and the N-oxide of pyridine., These structures support a model in which inhibitors are anchored by the, invariant glutamine at one end and the metal-pocket residues at another, end. This model provides explanations for most of the observed, structure-activity relationship and the metal ion dependency of the, catechol-ether based inhibitors and should facilitate their further, design.

Disease

Known disease associated with this structure: Stroke, susceptibility to, 1 OMIM:[600129]

About this Structure

2FM0 is a Single protein structure of sequence from Homo sapiens with ZN, MG and M98 as ligands. Active as 3',5'-cyclic-nucleotide phosphodiesterase, with EC number 3.1.4.17 Full crystallographic information is available from OCA.

Reference

Enantiomer discrimination illustrated by the high resolution crystal structures of type 4 phosphodiesterase., Huai Q, Sun Y, Wang H, Macdonald D, Aspiotis R, Robinson H, Huang Z, Ke H, J Med Chem. 2006 Mar 23;49(6):1867-73. PMID:16539372

Page seeded by OCA on Mon Nov 12 22:07:24 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools